Retevmo 00002-3977-60

Generic: Selpercatinib

Package NDC

00002-3977-60

Manufacturer: Eli Lilly And Company
Dosage Form: Capsule
Route: Oral
Product Type: Human Prescription Drug
Marketing Start: May 8, 2020
Listing Expires: December 31, 2026
Application: NDA213246

Need to source Retevmo? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Selpercatinib	40 mg/1

Drug Class

Kinase Inhibitor [EPC]Breast Cancer Resistance Protein Inhibitors [MoA]Cytochrome P450 2C8 Inhibitors [MoA]

Selected Package

00002-3977-60Selected

60 CAPSULE in 1 BOTTLE (0002-3977-60)